Aceprobe Technologies (India) Private Limited

Aceprobe Technologies (India) Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U74900DL2009PTC189137 Incorporated 02 April 2009 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company healthcare MSME · Micro
Data last updated
Revenue · FY 2025
₹5.08 Cr
▼ 39% YoY
Net profit · FY 2025
₹11.22 Lakh
Net margin 2.2%
EBITDA · FY 2025
₹22.32 Lakh
EBITDA margin 4.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
17 yrs
Est. 2009
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered

About Aceprobe Technologies (India) Private Limited

Data last updated:

Aceprobe Technologies (India) Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the healthtech and medical tech solutions segment of the healthcare sector. It was incorporated on 02 April 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2009PTC189137. Its GSTIN is 07AAHCA6837H2ZH (Delhi). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Puneet Chandna and Bindia Chandna.

Its last annual general meeting (AGM) was held on 07 October 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C – 2/296 1st Floor Block C – 2 Plot No. 296 Jan, Akpuri, New Delhi, Delhi, India – 110058.

As per the financials filed for FY 2025, the company reported a revenue of ₹5.08 Cr, a decline of 39% compared to the previous year. For the same year it recorded a net profit of ₹11.22 Lakh (net margin 2.2%) and EBITDA of ₹22.32 Lakh (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 74% over three years and 100% over five years.

The company is associated with 1 brand: Aceprobe. Court records list 2 cases involving the company, including 2 filed by the company. The company has 1 deal on record (1 secondary share transfer); the latest was in March 2010.

Aceprobe Technologies (India) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0000949). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aceprobe.com.

Company details

CIN U74900DL2009PTC189137
Registration Number 189137
Incorporation Date 02 April 2009
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 07 October 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0000949

Recognitions & Rankings of Aceprobe Technologies (India)

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-03-0000949

Contact details

Aceprobe Technologies (India) Private Limited's registered office is in New Delhi, Delhi. Its website is aceprobe.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    C – 2/296 1st Floor Block C – 2 Plot No. 296 Jan, Akpuri, New Delhi, Delhi, India – 110058
  • Industry
    Healthcare, HealthTech & Medical Tech Solutions

To see the full contact details of Aceprobe Technologies (India) Private Limited, buy the company report.

Comprehensive company report
Aceprobe Technologies (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Aceprobe Technologies (India) operates one associated brand: Aceprobe. Each brand links to its own profile.

BrandDescriptionWebsite
Healthcare services involving diagnostics, therapy, and biotechnology innovations.aceprobe.com

Business activity

The main business activity of Aceprobe Technologies (India) is manufacturing. In detail, this covers manufacture of electrical equipment.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing27Manufacture of electrical equipment

To see the full business activity and turnover split of Aceprobe Technologies (India) Private Limited, buy the company report.

Financials of Aceprobe Technologies (India) Private Limited

FY 2024 filings available

Aceprobe Technologies (India) Private Limited reported revenue of ₹5.08 Cr (down 39% YoY) for FY 2025.

Revenue · FY 2025
₹5.08 Cr ▼ 39%
Net profit · FY 2025
₹11.22 Lakh margin 2.2%
EBITDA · FY 2025
₹22.32 Lakh margin 4.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 39%
3 years · compounded
▲ 74%
5 years · compounded
▲ 100%
EBITDA CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 146%
5 years · compounded
▲ 89%

Revenue fell 39% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 100%. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹22.32 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹11.22 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.4%
Net Profit Margin2.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Aceprobe Technologies (India) Private Limited, buy the company report.

Board of directors of Aceprobe Technologies (India) Private Limited

Aceprobe Technologies (India) has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Puneet ChandnaDirector22 Jun 200917 Years 4 MonthsCurrent
Bindia ChandnaDirector22 Jun 200917 Years 4 MonthsCurrent

Auditor

Aceprobe Technologies (India) Private Limited is audited by SANJEEV MIGLNI AND ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SANJEEV MIGLNI AND ASSOCIATESFY 2023020887N

Shareholding

The shareholding of Aceprobe Technologies (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Aceprobe Technologies (India) Private Limited, buy the company report.

Deals & funding

Aceprobe Technologies (India) Private Limited has 1 deal on record (1 secondary share transfer); the latest was in March 2010.

Total deals
1
Secondary share transfer
1

Deals on record (1 of 1)

WhenDealAmountParties
Mar 2010Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Aceprobe Technologies (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Aceprobe Technologies (India) has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
07AAHCA6837H2ZHDelhiActive29 Sep 2019

To see the full GST registrations and return filing status of Aceprobe Technologies (India) Private Limited, buy the company report.

Recent activity

Aceprobe Technologies (India) Private Limited has 5 board changes on record since 2009: 2 appointments and 3 cessations. The latest: Parampreet Singh ceased to be Director on 02 Jul 2009.

AGM
Aceprobe Technologies (India) Private Limited last Annual general meeting of members was held on 07 Oct 2024 as per latest MCA records.
Filing
Aceprobe Technologies (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Parampreet Singh ceased to be Director.
Ceased
Sitaram Gopal ceased to be Director.
Ceased
Viswanath Venkata Dhulipala ceased to be Director.
Appointed
Bindia Chandna was appointed as Director.
Appointed
Puneet Chandna was appointed as Director.
Incorporation
02 Apr 2009
Aceprobe Technologies (India) Private Limited was registered on 02 Apr 2009 with Roc Delhi & aged 17 years 6 months as per MCA records.

Frequently asked questions

Aceprobe Technologies (India) is an active private limited company based in New Delhi, Delhi, India. The company works in healthtech and medical tech solutions, within the healthcare industry. It was incorporated on 02 April 2009 (17+ years old) and is registered under CIN U74900DL2009PTC189137.

Aceprobe Technologies (India) has 2 current directors:

The latest financial statements of Aceprobe Technologies (India) on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 07 October 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Aceprobe Technologies (India) is 07AAHCA6837H2ZH, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Aceprobe Technologies (India) is U74900DL2009PTC189137. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Aceprobe Technologies (India) has 2 court cases on record: 2 filed by the company.

Aceprobe Technologies (India) was incorporated on 02 April 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.

Aceprobe Technologies (India) has 1 deal on record (1 secondary share transfer); the latest was in March 2010.

Parampreet Singh ceased to be Director on 02 Jul 2009. Sitaram Gopal ceased to be Director on 02 Jul 2009. Viswanath Venkata Dhulipala ceased to be Director on 02 Jul 2009. Aceprobe Technologies (India) has 5 board changes on record in total.

Yes, Aceprobe Technologies (India) is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0000949).